TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05727852

Intervention type: DIAGNOSTIC_TEST
Intervention: Breath test using the Compact PTR-TOF-MS
Description: Breath samples will be analyzed with a proton-transfer reaction mass spectrometer (Compact PTR-MS, Ionicon, Austria) to obtain eVOCs profiles listed as ions at various mass-to-charge ratios (m/z).

Intervention type: DIAGNOSTIC_TEST
Intervention: Breath test using the Compact PTR-TOF-MS
Description: Breath samples will be analyzed with a proton-transfer reaction mass spectrometer (Compact PTR-MS, Ionicon, Austria) to obtain eVOCs profiles listed as ions at various mass-to-charge ratios (m/z).

Intervention type: DIAGNOSTIC_TEST
Intervention: Portable cardiac monitor CardioQvark
Description: Record an electrocardiogram (ECG) in one lead with an assessment of the pulse wave using a portable cardiac monitor CardioQvark (Russia, LLC L Card , RU No. RZN 2019/8124 dated February 15, 2019) once. Devices automatically transfer data to the A\&D Connect app paired with it (link). When transferring data, they are completely protected. The data obtained using the application must be sent to the specialists of the research group in a depersonalized form.

Intervention type: DIAGNOSTIC_TEST
Intervention: Portable cardiac monitor CardioQvark
Description: Record an electrocardiogram (ECG) in one lead with an assessment of the pulse wave using a portable cardiac monitor CardioQvark (Russia, LLC L Card , RU No. RZN 2019/8124 dated February 15, 2019) once. Devices automatically transfer data to the A\&D Connect app paired with it (link). When transferring data, they are completely protected. The data obtained using the application must be sent to the specialists of the research group in a depersonalized form.

Intervention type: DIAGNOSTIC_TEST
Intervention: Assessment of arterial stiffness using the VaSera VS-1500N
Description: Assessment of arterial stiffness using the VaSera VS-1500N Fukuda Denshi device by non-invasive measurement of blood pressure in four limbs with simultaneous recording of ECG, PCG and pulse waves on the carotid, femoral arteries, as well as on the arteries of four limbs.

Intervention type: DIAGNOSTIC_TEST
Intervention: Assessment of arterial stiffness using the VaSera VS-1500N
Description: Assessment of arterial stiffness using the VaSera VS-1500N Fukuda Denshi device by non-invasive measurement of blood pressure in four limbs with simultaneous recording of ECG, PCG and pulse waves on the carotid, femoral arteries, as well as on the arteries of four limbs.
Study: NCT06320262

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wet cupping therapy (WCT)
Description: Type of cupping: Triple-stage wet cupping therapy (Hijama) will be used; sucking, scarification, sucking.~Cupping points will include one cup on the posterior median line, in the depression below the processus spinosus of the 7th cervical vertebra (Alkahil area); two points in the inter-scapular region 3cm lateral to the lower border of the spinous process of the 3rd thoracic vertebra, two points at inferior angle of the scapula (3cm lateral to lower border of the spinous process of the 7th thoracic vertebra, 2 points at lumbar regions, in addition to the most painful areas.~After the procedure: Areas of cupping will be covered using sterile gauze. All used tools and materials will be collected in red bags to ensure proper waste disposal. Sharp objects will be disposed of in the sharps disposal box. Telephone follow-up with all patients 48 hours after cupping will be done.
Study: NCT05676840

Intervention type: PROCEDURE
Group type: OTHER
Intervention: orthodontic treatment with fixed appliances
Description: comprehensive orthodontic treatment with fixed orthodontic appliances for the correction of misaligned teeth.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: orthodontic treatment with fixed appliances
Description: comprehensive orthodontic treatment with fixed orthodontic appliances for the correction of misaligned teeth.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: orthodontic treatment with fixed appliances
Description: comprehensive orthodontic treatment with fixed orthodontic appliances for the correction of misaligned teeth.
Study: NCT05949164

Intervention type: BEHAVIORAL
Intervention: Insomnia
Description: The primary exposure is insomnia

Intervention type: BEHAVIORAL
Intervention: Insomnia
Description: The primary exposure is insomnia
Study: NCT05242120

Intervention type: OTHER
Intervention: Survey to access the impact of COVID 19 on anesthesia residency
Description: This is a cross-sectional study using an online survey will be conducted on 75 anesthesia residents in Cairo University hospitals. Invitations were sent to residents' groups on WhatsApp. Study objectives were clearly explained at the beginning of the survey, and the participants were encouraged to roll out the survey to as many physicians as possible. This survey contains 62-question, divided into four main sections
Study: NCT04986514

Intervention type: OTHER
Intervention: Bio-banking without genetic analysis
Description: For patients included in SCLERO-BIOBANK study, 2 blood samples will be collected at each SSc evaluation (usually once a year), in addition to the routine care blood collection.
Study: NCT05657808

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 1.1 Usage
Description: Participants will use Radicle Rest Active Product 1.1 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 1.2 Usage
Description: Participants will use Radicle Rest Active Product 1.2 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 2.1 Usage
Description: Participants will use Radicle Rest Active Product 2.1 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 2.2 Usage
Description: Participants will use Radicle Rest Active Product 2.2 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 1
Description: Participants will use Placebo Control Form 1 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 2
Description: Participants will use Placebo Control Form 2 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 3
Description: Participants will use Placebo Control Form 3 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 3.1 Usage
Description: Participants will use Radicle Rest Active Product 3.1 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 4
Description: Participants will use Placebo Control Form 4 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 4.1 Usage
Description: Participants will use Radicle Rest Active Product 4.1 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 4.2 Usage
Description: Participants will use Radicle Rest Active Product 4.2 as directed for a period of 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 4.3 Usage
Description: Participants will use Radicle Rest Active Product 4.3 as directed for a period of 6 weeks.
Study: NCT05290285

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Amino-Ther Pro
Description: Food supplements

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Maltodextrin
Study: NCT05998057

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: Exercises:~Lunge to Hamstrings Stretch 3 sets of 30 seconds~* Standing Hip Out 3 sets of 30sec~* 90-90 Hip Stretch 3 sets of 30 seconds~* World's Greatest Stretch 3 sets of 30 seconds~* Star Excursion 3 sets of 5 reps~* Side Jumps+ Balance 3 sets of 10 reps~* Forward Hops + Balance 3 sets of 10 reps~* Squat 3 sets of 10 reps~* Squat Jump 3 sets of 10 reps~* Jumping Spider Push-up 3 sets of 10 reps~* Double Leg Vertical Jump 3 sets of 10 reps~* Broad Jumps 3 sets of 10 reps~* Lateral Box Shuffles 3 sets of 10 reps~* Plank 3 sets of 30 seconds~* Side Plank 3 sets of 30 seconds~* Bird Dog 3 sets of 10 reps~* Glute Bridge 3 sets of 10 reps~* Single Leg Glute Bridge 3 sets of 10 reps~* Single Toe Raises 3 sets of 30sec~* Nordic Hamstrings 3 sets of 10 reps~* Monster Walk 3 sets of 10 reps

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: control
Description: The control group was asked to continue the standard (routine) classical training training (5 days/12 weeks).
Study: NCT05525481

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Description: Hormone therapy
Study: NCT04265105

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fluticasone-vilanterol
Description: LABA-ICS combination Inhaled Long acting Beta agonist and inhaled corticosteroid

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard Preparation
Description: inhaled SABA or Inhaled corticosteroid
Study: NCT04944199

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical Activity
Description: Intervention group participants will be enrolled in a standardized step-based program to gradually increase their physical activity. Daily steps will be measured via a pedometer application on a smartphone or wearable device, with a gradual increase in the goal on a weekly basis, with a target intervention of around 4-6 weeks in total. The first week's step count will be used to calculate a baseline step count for the week. At the start of each week, the participants will be asked to increase their daily step counts by 1,000.
Study: NCT06262126

Intervention type: OTHER
Group type: OTHER
Intervention: Virtual Reality
Description: Virtual Reality therapy
Study: NCT04016766

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile app prepartying intervention
Description: The intervention is comprised of a theoretically-informed and empirically-supported, brief, accessible, and personalized intervention to address prepartying drinking. the prepartying intervention app will be tailored toward an individual's personal goals, beliefs (perceptions, expectancies, self-efficacy), and behavior (protective strategies), and focus on the core components of brief interventions that have been cited as constructs that mediate the effects of multiple component intervention programs (e.g., correcting perceived norms, use of protective behavioral strategies, increased self-efficacy, challenging expectancies, feedback on blood alcohol level).
Study: NCT04923282

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: single 1-hour IV infusion of 0.8 mg/kg recAP
Description: Intravenous infusion

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: single 1-hour IV infusion of 1.6 mg/kg recAP
Description: Intravenous infusion

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: single 1-hour IV infusion of 3.2 mg/kg recAP
Description: Intravenous infusion

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: 1-hour infusions of 1.6 mg/kg recAP on Days 1, 2 and 3
Description: Intravenous infusion

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Intravenous infusion

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Intravenous infusion

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Intravenous infusion

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Intravenous infusion
Study: NCT06406296

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Description: Acceptance and Commitment Therapy methods were focused on promoting Values clarification, Acceptance, Cognitive defusion, Committed action and Flexible attention to the present moment, and included methods such as the Garden Metaphor, Funeral exercise or Mindfulness training.
Study: NCT05475080

Intervention type: DRUG
Intervention: Antiplatelet Drug
Description: Any antiplatelet drug or combination

Intervention type: DRUG
Intervention: Anticoagulant
Description: Any anticoagulante

Intervention type: PROCEDURE
Intervention: Endovascular
Description: Angioplasty +- stent

Intervention type: PROCEDURE
Intervention: Surgery
Description: Endarterectomy
Study: NCT04660565

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone and Belimumab
Description: Prednisone/prednisolone: started at 0.6-0. 8mg/kg.d for 2 to 4 weeks, tapered at 5mg per 1-2 weeks to equal to or less than 5mg per day in 3 months. Belimumab will start at the same time as the prednisone induction.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Prednisone/prednisolone: started at 0.6-0. 8mg/kg.d for 2 to 4 weeks, tapered at 5mg per 1-2 weeks to equal to or less than 5mg per day in 3 months.
Study: NCT05675969

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Blood sample
Description: Collection of 2 additional tubes of 4.5mL of citrate blood

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: Collection of 2 additional tubes of 4.5mL of citrate blood
Study: NCT06237504

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SaCoVLM™
Description: Patients will receive general anesthesia with their airways maintained with the SaCoVLM, which is a newer supraglottic airway device with a video port to directly visualize the upper airway.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ambu®Auragain™
Description: Patients will receive general anesthesia with their airways maintained with the Ambu Auragain, which is a conventional 2nd generation supraglottic airway device.
Study: NCT05013541

Intervention type: OTHER
Intervention: No intervention
Description: Observational study, standard record of need to void during cystometry
Study: NCT05927155

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LABA
Description: Inhalation of 4 puffs of 2,5 µg of a long-acting beta2-agonist (LABA-olodaterol) administered via a spacer device

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LAMA
Description: Inhalation of 4 puffs of 2,5 µg of a long-acting muscarinic antagonist (LAMA-tiotropium) administered via a spacer device
Study: NCT05895812

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deuremidevir Hydrobromide Tablets
Description: JT001 single dose, 0.3g

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deuremidevir Hydrobromide Tablets
Description: JT001 single dose, 0.3g

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deuremidevir Hydrobromide Tablets
Description: JT001 single dose, 0.3g
Study: NCT05349071

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methylprednisolone
Description: a single preoperative dose of 500 mg of methylprednisolone diluted in 250 mL of physiological saline 2 hours before surgery as a 30-minute infusion.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: physiological saline
Description: a single preoperative dose of 250 mL of physiological saline 2 hours before surgery as a 30-minute infusion.
Study: NCT05857488

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transnasal introduction tube
Description: Imaging of the GI tract using the transnasal introduction tube and system. Optional gut microbiome sample collection using the microbiome brush and/or intestinal potential difference measurement using the intestinal potential difference probe.
Study: NCT05766696

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART)
Description: Conventional glass-ionomer restorations are placed using the Atraumatic Restorative Treatment (ART) technique. Essentially, cavities are prepared using hand instrument excavators. Afterwards, the cavity is conditioned (using a 10% polyacrylic acid conditioner) and cleaned, with subsequent insertion of a conventional restorative glass-ionomer. During the curing phase, Vaseline will be applied to all restoration surfaces for moisture protection.~The treatment will be conducted in a class room.~As concomitant treatment, all participants will receive supervised toothbrushing during the study using 1,450 ppm fluoride toothpaste once a day.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Cavity Preparation
Description: Conventional glass-ionomer restorations are placed after conventional cavity preparation. Essentially, cavities are prepared using rotary instruments/diamond burs. Afterwards, the cavity is conditioned (using a 10% polyacrylic acid conditioner) and cleaned, with subsequent insertion of a conventional restorative glass-ionomer. During the curing phase, Vaseline will be applied to all restoration surfaces for moisture protection.~The treatment will be conducted in a mobile clinic.~As concomitant treatment, all participants will receive supervised toothbrushing during the study using 1,450 ppm fluoride toothpaste once a day.
Study: NCT06422897

Intervention type: OTHER
Intervention: anterior segment optical coherence tomography
Description: surgically treated corneal perforation by amniotic membrane graft and platelet rich plasma clot is assessed by anterior segment optical coherence tomography 1 month postoperative
Study: NCT05605886

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Solvazinc 50mg
Description: Patients will receive a daily zinc supplement tablets of 50 mg in the morning after breakfast for 4 days prior to injections.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study: NCT05548322

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Different surfaces to be touched
Description: The participant will touch various different surfaces and textures, including ones of different temperature and including solids and liquids.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Different surfaces to be touched
Description: The participant will touch various different surfaces and textures, including ones of different temperature and including solids and liquids.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Different surfaces to be touched
Description: The participant will touch various different surfaces and textures, including ones of different temperature and including solids and liquids.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Different surfaces to be touched
Description: The participant will touch various different surfaces and textures, including ones of different temperature and including solids and liquids.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Different surfaces to be touched
Description: The participant will touch various different surfaces and textures, including ones of different temperature and including solids and liquids.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Different surfaces to be touched
Description: The participant will touch various different surfaces and textures, including ones of different temperature and including solids and liquids.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional state change
Description: The emotional state of the participant will be modulated by listening to music.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional state change
Description: The emotional state of the participant will be modulated by listening to music.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Description: The participant will receive electrical stimulation of single nerve fibers (a few microamps) to artificially excite an individual afferent.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Description: The participant will receive electrical stimulation of single nerve fibers (a few microamps) to artificially excite an individual afferent.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Description: The participant will receive electrical stimulation of single nerve fibers (a few microamps) to artificially excite an individual afferent.
Study: NCT05465252

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Krill Oil 500 MG
Description: Qualified subjects start to take supplementation from Day 1 in the trial. Specifically, subjects from Intervention group take 3 capsules of krill oil per day.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Olive Oil 500MG
Description: Qualified subjects start to take placebo from Day 1 in the trial. Specifically, subjects from placebo group take 3 capsules of olive oil , which has the same color and smell as the krill oil.
Study: NCT06403332

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: brief intervention
Description: The intervention for cohort A (intervention arm) based on brief intervention on alcohol consumption performed by a psycologist, medical visit peformed by an hepatologist including assessment of underlying liver disease with non invasive test (i.e Fibroscan and lab work).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: brief intervention
Description: The intervention for cohort A (intervention arm) based on brief intervention on alcohol consumption performed by a psycologist, medical visit peformed by an hepatologist including assessment of underlying liver disease with non invasive test (i.e Fibroscan and lab work).
Study: NCT05785676

Intervention type: DEVICE
Intervention: Filter implantation
Description: Implantation of OATF ALN vena cava filter
Study: NCT04780997

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: Microsoft Xbox Kinect® was used for virtual reality exercises
Study: NCT05268913

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI scan
Description: Participants will undertake a magnetic resonance imaging scan.

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI scan
Description: Participants will undertake a magnetic resonance imaging scan.

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI scan
Description: Participants will undertake a magnetic resonance imaging scan.

Intervention type: BIOLOGICAL
Intervention: Blood test
Description: Participants will undertake a fasting blood test.

Intervention type: BIOLOGICAL
Intervention: Blood test
Description: Participants will undertake a fasting blood test.

Intervention type: BIOLOGICAL
Intervention: Blood test
Description: Participants will undertake a fasting blood test.
Study: NCT05751603

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sugammadex
Description: sugammadex is administered just after extubation
Study: NCT04752904

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ClearSight System
Description: Non-invasive, continuous blood pressure is monitored using ClearSight Sytem